BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4352167)

  • 21. A hemodynamic comparison of essential and renovascular hypertension. Cardiac output and total peripheral resistance: supine and tilted patients.
    Frohlich ED; Ulrych M; Tarazi RC; Dustan HP; Page IH
    Circulation; 1967 Feb; 35(2):289-97. PubMed ID: 6022798
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological basis of the symptomatic treatment of arterial hypertension. I. Hemodynamic effects, mechanisms of action and side effects of antihypertensive agents].
    Fournier A; Lagrue G; Schmitt H
    Nouv Presse Med; 1973 Oct; 2(38):2539-46. PubMed ID: 4148700
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
    Atkinson J; Lüthi P; Péra-Bally R; Peters-Haefeli L
    J Pharmacol Exp Ther; 1982 May; 221(2):453-60. PubMed ID: 6281416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Equilibration of the treatment of severe arterial hypertension. Significance of d-1 propranolol].
    Ménard J; Corvol P; Alexandre JM; Meignan M; N'Guyen-Phanh-Tam
    Nouv Presse Med; 1975 Jan; 4(1):17-20. PubMed ID: 806894
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of propranolol on various types of hypertension in the rat].
    Pessina AC; Corgnati A; Maranò A; Palatini P; Oneglia C
    Boll Soc Ital Cardiol; 1976; 21(6):951-8. PubMed ID: 1031069
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemodynamic effect of propranolol therapy in relationship to renin status and plasma catecholamines in primary hypertension.
    Vlachakis ND
    J Clin Pharmacol; 1980 Jan; 20(1):20-9. PubMed ID: 6987282
    [No Abstract]   [Full Text] [Related]  

  • 27. A new look at the hypertension problem: the role of the renin system for analysis and treatment.
    Laragh JH
    Compr Ther; 1985 Oct; 11(10):6-17. PubMed ID: 3902342
    [No Abstract]   [Full Text] [Related]  

  • 28. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical-physiological correlations in the development of hypertensive heart disease.
    Frohlich ED; Tarazi RC; Dustan HP
    Circulation; 1971 Sep; 44(3):446-55. PubMed ID: 4255490
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of propranolol in the treatment of hypertension].
    Mikhaĭlov AA
    Kardiologiia; 1975 Aug; 15(8):146-52. PubMed ID: 1195545
    [No Abstract]   [Full Text] [Related]  

  • 32. Minoxidil--an alternative to nephrectomy for refractory hypertension.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1973 Jul; 289(4):167-71. PubMed ID: 4268267
    [No Abstract]   [Full Text] [Related]  

  • 33. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 34. [The heart and arterial hypertension].
    Shkhvatsabaia IK
    Kardiologiia; 1982 Mar; 22(3):5-13. PubMed ID: 6210793
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemodynamics of renal arterial diseases and hypertension.
    Frohlich ED; Ulrych M; Tarazi RC; Dustan HP; Page IH
    Am J Med Sci; 1968 Jan; 255():29-37. PubMed ID: 4383912
    [No Abstract]   [Full Text] [Related]  

  • 36. Physiologic and biochemical profile of hypertension for rational clinical management.
    Sullivan JM
    Adv Intern Med; 1978; 23():219-49. PubMed ID: 343538
    [No Abstract]   [Full Text] [Related]  

  • 37. Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man.
    Ulrych M; Frohlich ED; Dustan HP; Page IH
    Circulation; 1968 Mar; 37(3):411-6. PubMed ID: 5640884
    [No Abstract]   [Full Text] [Related]  

  • 38. Observations of the role of body fluid volumes and plasma renin activity in the management of hypertension.
    Dorhout Mees EJ; Geyskes GG; Vos J; Boer P
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):335-46. PubMed ID: 1156038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes and hypertensive vascular disease. Mechanisms and treatment.
    Christlieb AR
    Am J Cardiol; 1973 Sep; 32(4):592-606. PubMed ID: 4361201
    [No Abstract]   [Full Text] [Related]  

  • 40. [beta-blockers in hypertension with renal failure].
    Guédon J; Aubert P; Lucsko M; Chaignon M
    Nouv Presse Med; 1978 Sep; 7(31):2795-7. PubMed ID: 30967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.